The DEEP project has received research funding from the European Union under the 7th Framework Programme

News

DEEP-experts group interview published on the International Innovation magazine

Aprile 8, 2015
|
Comments off
|

A collaborative group interview of four international researchers of the DEEP Network (Dr. Donato Bonifazi, Prof. Adriana Ceci, Prof. Oscar Della Pasqua and Prof. Amal El Beshlawy) appeared in Issue 162 of the International Innovation magazine in order to discuss the objectives and the outcomes of the European […]

Share
Read more →

DEEP-1: results demonstrate that adults and children should use the same dose/Kg of deferiprone

Aprile 8, 2015
|
Comments off
|

The DEEP-1 pharmacokinetic study evaluated the systemic exposure of DFP in the paediatric population aged from 1 month to < 6 years for which PK profile of deferiprone is unknown. This lack of information implies that so far the dosage of deferiprone in this age subset can […]

Share
Read more →

DEEP supports Rare Disease Day

Marzo 10, 2015
|
Comments off
|

The “Rare Disease Day” campaign, this year at its 8th edition, is becoming more and more persuading and widespread, by promoting communication among hospitals, clinical centres, physicians and patients altogether for the purpose of a better understanding and treatment of rare diseases.

What started off as an European […]

Share
Read more →

Italy: First Patients are successfully completing and concluding DEEP-2 study

Marzo 8, 2015
|
Comments off
|

Significant progresses have been made in patients’ enrolment in the DEEP-2 study (multicentre, randomized, open label, controlled trial aimed at comparing the efficacy of deferiprone and deferasirox in paediatric patients).

So far, 8 Italian centres have already started the patients’ enrollment: recently the Azienda Ospedaliera di Padova […]

Share
Read more →